1. 疾病领域
  2. 炎症和免疫系统疾病

Inflammation or Immune System Disease  (炎症和免疫系统疾病)

炎症或免疫系统疾病涉及一系列事件,始于急性炎症,发展为慢性炎症,最终在植入物周围形成肉芽组织和纤维囊,其驱动因素是异物反应,其特征是巨噬细胞和异物巨细胞在生物材料-组织界面处积聚。炎症和免疫系统疾病涉及机体免疫反应失调,导致免疫防御过度或不适当激活。这些疾病可能源于自身免疫性疾病(免疫系统攻击自身组织),或导致组织损伤和功能障碍的慢性炎症状态。免疫学是研究免疫系统的学科,致力于理解免疫和宿主防御病毒、细菌、真菌和寄生虫等病原体的潜在机制,从而为免疫相关疾病的发病机制和治疗提供新的见解。

Inflammation or immune system diseases involve a cascade of events starting with acute inflammation, progressing to chronic inflammation, and culminating in granulation tissue formation and fibrous capsule development around an implant, driven by a foreign body reaction characterized by the accumulation of macrophages and foreign body giant cells at the biomaterial-tissue interface. Inflammation and immune system diseases involve dysregulation of the body's immune responses, leading to excessive or inappropriate activation of immune defenses. These conditions can result from autoimmune disorders, where the immune system attacks self-tissues, or chronic inflammatory states that cause tissue damage and dysfunction. Immunology, the study of the immune system, focuses on understanding the mechanisms underlying immunity and host defense against pathogens like viruses, bacteria, fungi, and parasites, providing insights into the pathogenesis and treatment of immune-related disorders.

Inflammation or Immune System Disease (5):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N0385
    Gomisin J

    戈米辛J

    66280-25-9 99.97%
    Gomisin J 是一五味子来源的木脂素,可靶向 eNOSAMPK (LKB1CaMKIIβ)、fetuin-ANF-κBNrf2/HO-1 等多个靶点,且能通过血脑屏障。Gomisin J 通过激活 eNOS 增加 NO 生物利用度、激活 AMPK 通路调节脂代谢、抑制 fetuin-A 和 NF-κB 发挥抗炎作用、激活 Nrf2/HO-1 增强抗氧化能力等机制。Gomisin J 具有抗高血压、调节肝脂代谢、减轻脑缺血再灌注损伤等活性,可用于高血压、非酒精性脂肪肝、脑缺血再灌注损伤等研究。
    Gomisin J
  • HY-18706
    trans-Tranilast

    反-曲尼司特

    70806-55-2 98.99%
    trans-Tranilast (trans-MK-341) 是一种抗过敏剂, 用于研究支气管哮喘, 过敏性鼻炎和特应性皮炎。
    trans-Tranilast
  • HY-B1365
    Prednicarbate 73771-04-7 99.81%
    Prednicarbate 是一种外用皮质类固醇。Prednicarbate 可用于炎症性皮肤病的研究,如特应性皮炎。
    Prednicarbate
  • HY-106262
    Delcasertib 949100-39-4 98.21%
    Delcasertib (KAI-9803) 是有效,选择性的 δ 蛋白激酶C (δPKC) 抑制剂。Delcasertib (KAI-9803) 可改善急性心肌梗死动物模型的缺血再灌注损伤。
    Delcasertib
  • HY-P99886
    Pexelizumab

    培克珠单抗

    219685-93-5
    Pexelizumab (h5G1. 1-SC) 是一种针对 C5 补体成分的人源单链单克隆抗体。Pexelizumab 抑制凋亡 (apoptosis) 和白细胞浸润。Pexelizumab 可用于脑缺血再灌注损伤和心肌梗死的研究。
    Pexelizumab